TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 1 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,000 | -25.6% | 9,686 | +26.5% | 0.00% | – |
| Q2 2023 | $117,000 | -12.0% | 7,655 | +29.2% | 0.00% | – |
| Q1 2023 | $133,000 | -50.4% | 5,923 | -53.5% | 0.00% | – |
| Q4 2022 | $268,000 | +235.0% | 12,740 | +292.1% | 0.00% | – |
| Q3 2022 | $80,000 | -45.6% | 3,249 | -46.4% | 0.00% | – |
| Q2 2022 | $147,000 | -6.4% | 6,065 | -0.8% | 0.00% | – |
| Q1 2022 | $157,000 | -61.2% | 6,113 | -53.1% | 0.00% | – |
| Q4 2021 | $405,000 | +101.5% | 13,038 | +57.0% | 0.00% | – |
| Q3 2021 | $201,000 | +240.7% | 8,306 | +104.9% | 0.00% | – |
| Q2 2021 | $59,000 | +37.2% | 4,053 | +132.7% | 0.00% | – |
| Q1 2021 | $43,000 | +4200.0% | 1,742 | +3315.7% | 0.00% | – |
| Q4 2020 | $1,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
| Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
| Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
| GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
| ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
| HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
| MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
| Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
| Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |